4
Changes in Ownership
MapLight Therapeutics, Inc. Filed Acc 0002021233-26-000012
Chief Medical Officer sold 47,158 shares at an average $36.78 ($1,734,490)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Foff Erin Pennock · Chief Medical Officer
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-15 | Sale : show line 1 in the form 10b5-1 | −7,155 | $36.16 | $258,725 | 338,904 | D |
| 2026-07-15 | Sale : show line 2 in the form 10b5-1 | −7,845 | $37.04 | $290,579 | 331,059 | D |
| 2026-07-15 | Sale : show line 3 in the form 10b5-1 | −4,465 | $36.00 | $160,740 | 326,594 | D |
| 2026-07-15 | Sale : show line 4 in the form 10b5-1 | −8,972 | $36.99 | $331,874 | 317,622 | D |
| 2026-07-15 | Sale : show line 5 in the form 10b5-1 | −18 | $37.54 | $676 | 317,604 | D |
| 2026-07-16 | Sale : show line 6 in the form 10b5-1 | −9,163 | $36.46 | $334,083 | 308,441 | D |
| 2026-07-16 | Sale : show line 7 in the form 10b5-1 | −5,865 | $37.26 | $218,530 | 302,576 | D |
| 2026-07-16 | Sale : show line 8 in the form 10b5-1 | −19 | $37.96 | $721 | 302,557 | D |
| 2026-07-17 | Sale : show line 9 in the form 10b5-1 | −3,656 | $37.90 | $138,562 | 298,901 | D |
| Open-market sales · 47,158 sh · avg $36.78 · $1,734,490 | ||||||
Loading xslF345X06/form4-07182026_010714.xml…